Dapacan M 10mg/1000mg Tablet is a medication that combines Dapagliflozin and Metformin, categorized under Antidiabetics. It is predominantly prescribed for the management of type 2 diabetes mellitus when other treatments fail to provide adequate control. Dapacan M 10mg/1000mg Tablet may be used in combination with insulin or GLP-1 receptor agonists, such as liraglutide, to optimize its effects.

Before initiating treatment with Dapacan M 10mg/1000mg Tablet, it is imperative to undergo blood tests to evaluate kidney function. Patients should refrain from alcohol consumption while taking this medication, as it can heighten the risk of lactic acidosis, a serious condition.

Certain medical conditions warrant caution or avoidance of Dapacan M 10mg/1000mg Tablet, such as liver disease, severe kidney disease, recent heart attack, heart failure, shock, severe infections, diabetic ketoacidosis, among others. Pregnant and breastfeeding women should consult with their healthcare provider before starting this medication, as it may have potential risks. Additionally, the drug is not recommended for use in children and adolescents under 18 years of age.

Elderly patients aged 65 years or above should use Dapacan M 10mg/1000mg Tablet with caution and guidance from their healthcare provider. Common side effects may include nausea, vomiting, diarrhea, stomach pain, and loss of appetite. It is advisable to promptly contact a physician if any of these symptoms worsen during the course of treatment.